421 related articles for article (PubMed ID: 16026863)
1. Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine.
Hamkar R; Jalilvand S; Mokhtari-Azad T; Nouri Jelyani K; Dahi-Far H; Soleimanjahi H; Nategh R
J Virol Methods; 2005 Dec; 130(1-2):59-65. PubMed ID: 16026863
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of recent primary rubella virus infections: significance of glycoprotein-based IgM serology, IgG avidity and immunoblot analysis.
Wandinger KP; Saschenbrecker S; Steinhagen K; Scheper T; Meyer W; Bartelt U; Enders G
J Virol Methods; 2011 Jun; 174(1-2):85-93. PubMed ID: 21513745
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women.
Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R
East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431
[TBL] [Abstract][Full Text] [Related]
4. [Usefulness of determining low-avidity IgG antibodies in the diagnosis of primary rubella infection in pregnant women].
Lafarga B; Noguera FJ; Pérez MC; Copado R; García A; Soria E
Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):413-8. PubMed ID: 9887628
[TBL] [Abstract][Full Text] [Related]
5. Significance of avidity and immunoblot analysis for rubella IgM-positive serum samples in pregnant women.
Hofmann J; Liebert UG
J Virol Methods; 2005 Dec; 130(1-2):66-71. PubMed ID: 16024097
[TBL] [Abstract][Full Text] [Related]
6. Performance of the immunoglobulin G avidity and enzyme immunoassay IgG/IgM screening tests for differentiation of the clinical spectrum of toxoplasmosis.
Tanyuksel M; Guney C; Araz E; Saracli MA; Doganci L
J Microbiol; 2004 Sep; 42(3):211-5. PubMed ID: 15459650
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of rubella IgM enzyme immunoassays.
Tipples GA; Hamkar R; Mohktari-Azad T; Gray M; Ball J; Head C; Ratnam S
J Clin Virol; 2004 Jul; 30(3):233-8. PubMed ID: 15135741
[TBL] [Abstract][Full Text] [Related]
8. Comparison of serological methods for the detection of IgG and IgM antibodies to rubella virus.
Arista S; Pistoia D; Titone L; Ammatuna P
Microbiologica; 1987 Apr; 10(2):151-60. PubMed ID: 3587064
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the new ARCHITECT Rubella IgM assay.
Eichler R; Prostko J; Fischer C; Hausmann M; Christ H
J Clin Virol; 2007 Jul; 39(3):182-7. PubMed ID: 17543576
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of commercial rubella immunoglobulin G avidity assays.
Mubareka S; Richards H; Gray M; Tipples GA
J Clin Microbiol; 2007 Jan; 45(1):231-3. PubMed ID: 17093027
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response after primary rubella virus infection and after vaccination.
Vauloup-Fellous C; Grangeot-Keros L
Clin Vaccine Immunol; 2007 May; 14(5):644-7. PubMed ID: 17344342
[TBL] [Abstract][Full Text] [Related]
12. [Demonstration of Rubella-specific IgG and IgM antibody (sub) classes using the enzyme immunoassay (EIA)].
Doerr HW; Fleischer G; Wiesmann M
Immun Infekt; 1984 Feb; 12(1):21-8. PubMed ID: 6398271
[TBL] [Abstract][Full Text] [Related]
13. Clinical rubella reinfection during pregnancy in a previously vaccinated woman.
Aboudy Y; Barnea B; Yosef L; Frank T; Mendelson E
J Infect; 2000 Sep; 41(2):187-9. PubMed ID: 11023770
[TBL] [Abstract][Full Text] [Related]
14. Rubella immune status of pregnant and non-pregnant women in Istanbul, Turkey.
Seker S; Abasiyanik MF; Salih BA
Saudi Med J; 2004 May; 25(5):575-9. PubMed ID: 15138523
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two commercial immunoassays for the detection of anti-rubella IgM and IgG in pediatric patients.
Oliveira LC; Okay TS; Kawasato KH; Lima LP
J Immunoassay Immunochem; 2007; 28(3):297-306. PubMed ID: 17613675
[TBL] [Abstract][Full Text] [Related]
16. Inadvertent rubella vaccination of pregnant women: evaluation of possible transplacental infection with rubella vaccine.
Hamkar R; Jalilvand S; Abdolbaghi MH; Esteghamati AR; Hagh-Goo A; Jelyani KN; Mohktari-Azad T; Zahraei M; Nategh R
Vaccine; 2006 Apr; 24(17):3558-63. PubMed ID: 16510217
[TBL] [Abstract][Full Text] [Related]
17. [Detection of IgG antibodies against rubella virus using the "Rubella-IgG-EIA SSW" test kit].
Meisegeier B; Engelmann A; Pustowoit B; Thiel B; Hehme N; Koppatz G; Richter B; Mohr J; Sandow D
Z Gesamte Hyg; 1990 May; 36(5):254-7. PubMed ID: 2368455
[TBL] [Abstract][Full Text] [Related]
18. Measurement of avidity of specific IgG for verification of recent primary rubella.
Hedman K; Rousseau SA
J Med Virol; 1989 Apr; 27(4):288-92. PubMed ID: 2723615
[TBL] [Abstract][Full Text] [Related]
19. [Avidity of rubella IgG antibody in rubella virus infection].
Hoshiba T; Nishimoto H; Asamoto A; Yabuki Y
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Dec; 45(12):1389-93. PubMed ID: 8270822
[TBL] [Abstract][Full Text] [Related]
20. Dried blood spots versus sera for detection of rubella virus-specific immunoglobulin M (IgM) and IgG in samples collected during a rubella outbreak in Peru.
Helfand RF; Cabezas C; Abernathy E; Castillo-Solorzano C; Ortiz AC; Sun H; Osores F; Oliveira L; Whittembury A; Charles M; Andrus J; Icenogle J
Clin Vaccine Immunol; 2007 Nov; 14(11):1522-5. PubMed ID: 17881506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
